Curated Information
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.7.9
Powered by Cell Signaling Technology
Home > Curated Information Page > PubMed Id: 22306348
Nathanson NM (2012) Regulation of neurokine receptor signaling and trafficking. Neurochem Int 61, 874-8 22306348
This page summarizes selected information from the record referenced above and curated into PhosphoSitePlus®, a comprehensive online resource for the study of protein post-translational modifications (NAR, 2015, 43:D512-20). To learn more about the scope of PhosphoSitePlus®, click here.
Click on the protein name to open the protein page, and on the RSD number to open the site page.
Download

S782-p - gp130 (human)
Modsite: QVFSRsEsTQPLLDS SwissProt Entrez-Gene
Orthologous residues
gp130 (human): S782‑p, gp130 iso2 (human): , gp130 iso3 (human): S721‑p, gp130 (mouse): S780‑p, gp130 (rat): S781‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Relevant cell lines - cell types - tissues:  3T3-L1 (fibroblast)
Cellular systems studied:  cell lines
Species studied:  mouse
Enzymes shown to modify site in vitro
Type Enzyme
KINASE CAMK2A (human)
Upstream Regulation
Treatments, proteins and their effect on site modification: 
Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes
CAMK2A (human) increase
CAMK4 (human) increase
Downstream Regulation
Effect of modification (function):  receptor internalization, induced
Effect of modification (process):  signaling pathway regulation, transcription, inhibited

S1044-p - LIFR (human)
Modsite: WNLVsPDsPRsIDSN SwissProt Entrez-Gene
Orthologous residues
LIFR (human): S1044‑p, LIFR (mouse): S1039‑p, LIFR (rat): S1040‑p
Characterization
Methods used to characterize site in vivo mutation of modification site
Disease tissue studied:  neuroblastoma
Relevant cell lines - cell types - tissues:  NBFL
Cellular systems studied:  cell lines
Species studied:  human
Upstream Regulation
Treatments, proteins and their effect on site modification: 
Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes
ERK1 (human) increase
ERK2 (human) increase
Downstream Regulation
Effect of modification (process):  transcription, inhibited